Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Ligilactobacillus faecis WILCCON 0062: Genome sequencing

PROVIDER: PRJNA956725 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR24201568_1.fastq.gz	Fastqsanger.gz
	SRR24201569_1.fastq.gz	Fastqsanger.gz
	SRR24201569_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

Ligilactobacillus ubinensis strain:WILCCON 0076

Project description:Ligilactobacillus ubinensis WILCCON 0076: Genome sequencing

| PRJNA764831 | ENA

Ligilactobacillus faecis strain:YN2-84

Project description:Ligilactobacillus faecis strain:YN2-84 Genome sequencing

| PRJNA771777 | ENA

RNAsequencing of Ligilactobacillus agilis grown on Inulin and Lactose

Project description:RNAsequening revolutionized the bacterial gene expression analysis. The objective of this study was to identify the genes involved in metabolism of Inulin in Ligilactobacillus agilis. We have obtained a list of genes upregulated in Ligilactobacillus agilis when it is grown in 1% Inulin

2020-10-27 | GSE160177 | GEO

Clostridium neuense strain:WILCCON 0114

Project description:Clostridium neuense WILCCON 0114: Genome sequencing

| PRJNA1187786 | ENA

Lactiplantibacillus brownii strain:WILCCON 0030

Project description:Lactiplantibacillus brownii WILCCON 0030: Genome sequencing

| PRJNA1005019 | ENA

Mitsuokella sp. WILCCON 0060

Project description:Mitsuokella sp. WILCCON 0060 Genome sequencing

| PRJNA1161733 | ENA

Megasphaera sp. WILCCON 0056

Project description:Megasphaera sp. WILCCON 0056 Genome sequencing

| PRJNA1161732 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Bacteroides faecis MAJ27

Project description:Bacteroides faecis MAJ27 Genome Sequencing

| PRJNA72171 | ENA

Candidatus Clostridium helianthi strain:WILCCON 0112

Project description:Candidatus Clostridium helianthi WILCCON 0112: Genome sequencing

| PRJNA1187785 | ENA